NCT04816864

Brief Summary

Different studies for extracardiac vagal nerve stimulation (ECANS) have been published and confirmed the influence of the vagus nerve on automaticity and conduction properties of the sinus node, atria, atrioventricular node, as well as the His-Purkinje system (HPS) and ventricles. However, there are limited data on the clinical value and impact of ECANS as well as vagus nerve activity on the parameters of permanent His-bundle (HB) or left bundle branch (LBB) pacing. Moreover, there have been no prospective studies evaluating the feasibility and efficacy of ECANS and the management of ECANS-induced scenarios, such as an exit block, increase in pacing threshold, as well as vagally mediated arrhythmias and conduction abnormalities in patients with physiological conduction system pacing (HB/LBB pacing). The objective of the HIS-STORY study in humans is to evaluate the clinical value of ECANS in patients with HB/LBB pacing for further development of patient-centered management strategy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2021

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 21, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 25, 2021

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

December 20, 2022

Status Verified

December 1, 2022

Enrollment Period

3 years

First QC Date

March 21, 2021

Last Update Submit

December 19, 2022

Conditions

Keywords

His bundle pacingleft bundle branch pacingextracardiac vagal nerve stimulation

Outcome Measures

Primary Outcomes (1)

  • Loss of HB/LBB capture or significant increase in pacing threshold

    significant increase in pacing threshold = above the permanently programmed impulse amplitude of HB/LBB electrode induced by ECANS

    0-12 months after HB/LBB pacemaker implantation

Secondary Outcomes (2)

  • A nonsignificant increase in pacing threshold

    0-12 months after HB/LBB pacemaker implantation

  • Prolongation of the stimulus-QRS interval during HB/LBB pacing induced by ECANS

    0-12 months after HB/LBB pacemaker implantation

Other Outcomes (1)

  • Any arrhythmia induced by ECANS

    0-12 months after HB/LBB pacemaker implantation

Study Arms (2)

ECANS started from the right vagus nerve

ACTIVE COMPARATOR

superior ECANS and ultrasonography guided inferior ECANS

Diagnostic Test: extracardiac vagal nerve stimulation (ECANS) + EPS

ECANS started from the left vagus nerve

ACTIVE COMPARATOR

superior ECANS and ultrasonography guided inferior ECANS

Diagnostic Test: extracardiac vagal nerve stimulation (ECANS) + EPS

Interventions

The study intervention will consist of 3 steps, all of which will be performed under general anesthesia: 1. EPS with the measurement of parameters of atrioventricular conduction and programmed atrial and ventricular pacing. 2. ECANS of the right and the left vagus nerve (from the right and left internal jugular vein, respectively; patients will be randomized to start from the right or the left side) performed during: 1) the patient's spontaneous heart rhythm (if present); 2) HB/LBB pacing with permanently programmed impulse parameters; 3) HB/LBB pacing at a pacing threshold of +0.1 V; and 4) 5 minutes after intravenous injection of atropine (0.02-0.04 mg/kg). 3. EPS with the measurement of parameters of atrioventricular conduction and programmed atrial and ventricular pacing.

ECANS started from the left vagus nerveECANS started from the right vagus nerve

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • signed informed consent form
  • effective and stable HB or LBB pacing
  • sinus rhythm during the intervention procedure

You may not qualify if:

  • contraindications to invasive EPS
  • contraindications to general anesthesia
  • contraindications to atropine administration (e.g., glaucoma)
  • persistent atrial fibrillation or atrial flutter
  • pregnancy
  • diseases that may cause autonomic system neuropathy
  • use of medications that may affect the parasympathetic system
  • a history of cardiac surgery
  • a history of ablation due to arrhythmia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

4th Military Hospital, Cardiology Department

Wroclaw, Lower Silesian Voivodeship, 50-981, Poland

RECRUITING

Mazovian Speciality Hospital, Cardiology Department

Radom, Masovian Voivodeship, 26-617, Poland

RECRUITING

Subcarpathian Center for Cardiovascular Intervention

Sanok, Podkarpackie Voivodeship, 38-500, Poland

RECRUITING

Related Publications (10)

  • Abdelrahman M, Subzposh FA, Beer D, Durr B, Naperkowski A, Sun H, Oren JW, Dandamudi G, Vijayaraman P. Clinical Outcomes of His Bundle Pacing Compared to Right Ventricular Pacing. J Am Coll Cardiol. 2018 May 22;71(20):2319-2330. doi: 10.1016/j.jacc.2018.02.048. Epub 2018 Mar 10.

  • Kronborg MB, Mortensen PT, Poulsen SH, Gerdes JC, Jensen HK, Nielsen JC. His or para-His pacing preserves left ventricular function in atrioventricular block: a double-blind, randomized, crossover study. Europace. 2014 Aug;16(8):1189-96. doi: 10.1093/europace/euu011. Epub 2014 Feb 7.

  • Dandamudi G, Vijayaraman P. How to perform permanent His bundle pacing in routine clinical practice. Heart Rhythm. 2016 Jun;13(6):1362-6. doi: 10.1016/j.hrthm.2016.03.040. Epub 2016 Mar 22. No abstract available.

  • Josiak K, Nowak K, Fuglewicz A, Jagielski D, Banasiak W, Ponikowski P. Does right ventricular pacing increase the risk of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator? Kardiol Pol. 2014;72(4):381-4. doi: 10.5603/KP.2014.0073. No abstract available.

  • Sharma PS, Dandamudi G, Naperkowski A, Oren JW, Storm RH, Ellenbogen KA, Vijayaraman P. Permanent His-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice. Heart Rhythm. 2015 Feb;12(2):305-12. doi: 10.1016/j.hrthm.2014.10.021. Epub 2014 Oct 22.

  • Burri H, Jastrzebski M, Vijayaraman P. Electrocardiographic Analysis for His Bundle Pacing at Implantation and Follow-Up. JACC Clin Electrophysiol. 2020 Jul;6(7):883-900. doi: 10.1016/j.jacep.2020.03.005.

  • Zysko D, Gajek J, Kozluk E, Mazurek W. Electrocardiographic characteristics of atrioventricular block induced by tilt testing. Europace. 2009 Feb;11(2):225-30. doi: 10.1093/europace/eun299. Epub 2008 Nov 5.

  • Klank-Szafran M, Stec S, Sledz J, Janion M. [Radiofrequency ablation and cardioneuroablation for AVNRT and atrioventricular block]. Kardiol Pol. 2010 Jun;68(6):720-4. Polish.

  • Pachon JC, Pachon EI, Pachon JC, Lobo TJ, Pachon MZ, Vargas RN, Jatene AD. "Cardioneuroablation"--new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. Europace. 2005 Jan;7(1):1-13. doi: 10.1016/j.eupc.2004.10.003.

  • Stec S, Dobaj L, Sledz A, Stepien-Walek AM, Ton V, Sledz J. Cardioneuroablation for management of cardioinhibitory vasovagal syncope and pacemaker complications. HeartRhythm Case Rep. 2020 May 11;6(8):531-534. doi: 10.1016/j.hrcr.2020.04.021. eCollection 2020 Aug. No abstract available.

MeSH Terms

Interventions

Electrophysiologic Techniques, Cardiac

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Study Officials

  • Krystian Josiak, MD, PhD

    4th Military Clinical Hospital with Polyclinic, Poland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Krystian Josiak, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Krystian Josiak, MD, PhD

Study Record Dates

First Submitted

March 21, 2021

First Posted

March 25, 2021

Study Start

January 2, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

December 20, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations